Prosecution Insights
Last updated: October 01, 2026
Application No. 18/711,238

PRODUCTION OF HIGHLY ATTENUATED BEERS

Non-Final OA §102§103
Filed
May 17, 2024
Priority
Nov 24, 2021 — provisional 63/282,709 +1 more
Examiner
LEBLANC, KATHERINE DEGUIRE
Art Unit
1791
Tech Center
1700 — Chemical & Materials Engineering
Assignee
International N&h Denmark Aps
OA Round
1 (Non-Final)
35%
Grant Probability
At Risk
1-2
OA Rounds
1y 5m
Est. Remaining
70%
With Interview

Examiner Intelligence

Grants only 35% of cases
35%
Career Allowance Rate
213 granted / 616 resolved
-30.4% vs TC avg
Strong +36% interview lift
Without
With
+35.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
29 currently pending
Career history
661
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
64.1%
+24.1% vs TC avg
§102
8.8%
-31.2% vs TC avg
§112
22.3%
-17.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 616 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-4 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Asahi Breweries(English translation of WO2014/196265A1). Regarding claims 1,2, Asahi teaches a method of increasing attenuation in a fermented beverage such as beer comprising adding transglucosidase in a maltose depleted fermentate, the maltose being depleted by the presence of glucoamylase(example 1). Regarding claim 3, Asahi teaches that the fermentate has a concentration of less than 5mg/L(example 2), i.e. less than 0.0005%. Regarding claim 4, Asahi teaches that less than 3U/ml is added to the fermentate(p.3, 3rd paragraph). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 5-24 is/are rejected under 35 U.S.C. 103 as being unpatentable over Asahi Breweries(English translation of WO2014/196265A1). Regarding claims 5,6, Asahi teaches that less than 3U/ml is added to the fermentate(p.3, 3rd paragraph). Regarding claims 7,14,16, Asahi teaches that the transglucosidase can be added at any time in the fermentation process including at the beginning(p.3, 1st paragraph). Therefore, it would have been obvious to adjust the timing of the addition of the transglucosidase depending on the desired taste of the composition. Regarding claims 8-12, Asahi is silent on the rdf of the beer production. However, it would have been obvious to adjust the rdf(real degree of fermentation) depending on the taste desired in the final composition. Regarding claim 13, Asahi is silent on the apparent extract of the beer product. However, it would have been obvious to adjust the apparent extract depending on the taste desired in the final composition. Regarding claim 15, Asahi teaches adding glucoamylase to the fermentate(example 1). Regarding claims 17-24. Asahi is silent on the sequence identity of the transglucosidase. However, it would have been obvious to select any transglucosidase capable of performing the method of claim 1, as the applicant has not shown that the specific transglucosidase provides any unexpected properties. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHERINE D LEBLANC whose telephone number is (571)270-1136. The examiner can normally be reached 8AM-4PM EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Nikki Dees can be reached at 571-270-3435. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATHERINE D LEBLANC/Primary Examiner, Art Unit 1791
Read full office action

Prosecution Timeline

May 17, 2024
Application Filed
Sep 15, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12729247
INHIBITED POROUS GRANULAR STARCHES AND METHODS OF MAKING AND USING THEM
3y 11m to grant Granted Sep 08, 2026
Patent 12721366
MEDIUM/LOW GLYCAEMIC INDEX PRODUCTS AND METHODS
6y 1m to grant Granted Sep 01, 2026
Patent 12703843
METHOD AND SYSTEM FOR THE FILTRATION AND STABILIZATION OF ULTRA-HIGH GRAVITY ALCOHOLIC BEVERAGES
4y 10m to grant Granted Aug 11, 2026
Patent 12698396
BLUE PIGMENT AND METHOD FOR PRODUCING SAME
3y 5m to grant Granted Aug 04, 2026
Patent 12696905
High-Fat Flour Replacement and Methods of Preparation
3y 4m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
35%
Grant Probability
70%
With Interview (+35.8%)
3y 10m (~1y 5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 616 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month